As the new coronavirus continues to envelop much of the globe, a lab outside New York City is racing to find a antibody treatment that could temporarily protect from the illness — or even treat it.The biotech company Regeneron is in early development of a treatment that could guard against catching the coronavirus for several months using antibodies from mice that have been genetically modified with immune systems to mimic those of humans.Full coverage of the coronavirus outbreak”We are optimistic, because we’ve done this approach to treat many human diseases,” CEO Leonard Schleifer said.The process involves exposing the mice to a “pseudo coronavirus” — the virus without its ability to replicate — which was created by Regeneron scientists who hope the mice will then develop the right transferable antibodies to fight the virus in humans.”Over the course of the next several weeks, they will choose the best ones [antibodies], create this cocktail, put it in these cell lines that can be scaled up into these giant vats, and [it’s] off to the races,” Schleifer said.Let our news meet your inbox. The news and stories that matters, delivered weekday mornings.Most vaccines, like the flu shot, introduce the virus into the body

Continue To Full Article